Nutex Health Inc. (NASDAQ: NUTX) stock jumped 7.47% on Monday to $0.24 against a previous-day closing price of $0.22. With 3.96 million shares changed hands, the volume of the stock remained heavier than its average volume of 2.69 million shares. The 52-week range on NUTX shows that it touched its highest point at $2.46 and its lowest point at $0.21 during that stretch. It currently has a 1-year price target of $2.38. Beta for the stock currently stands at 0.71.
Top 5 EV Tech Stocks to Buy for 2023
The electric vehicle boom is accelerating – and fast. According a new report published by BloombergNEF, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now. Get our free report, "Top 5 EV Tech Stocks to Buy for 2023".
Click Here to Download the FREE Report.
Sponsored
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of NUTX was down-trending over the past week, with a drop of -6.46%, but this was down by -19.89% over a month. Three-month performance dropped to -43.37% while six-month performance fell -77.43%. The stock lost -89.55% in the past year, while it has lost -87.35% so far this year. A look at the trailing 12-month EPS for NUTX yields -0.67 with Next year EPS estimates of -0.01. For the next quarter, that number is -0.01. This implies an EPS growth rate of -82.70% for this year and 50.00% for next year.
Float and Shares Shorts:
At present, 656.56 million NUTX shares are outstanding with a float of 334.68 million shares on hand for trading. On Aug 30, 2023, short shares totaled 1.14 million, which was 0.17% higher than short shares on Jul 30, 2023. In addition to Dr. Thomas T. Vo M.B.A., M.D. as the firm’s Chairman & CEO, Dr. Warren Hosseinion M.D. serves as its Pres & Director.
Institutional Ownership:
Through their ownership of 6.35% of NUTX’s outstanding shares, institutional investors have minority control over the company. Other institutions hold 41.84% of NUTX, in contrast to 2.72% held by mutual funds. Shares owned by individuals account for 1.84%. As the largest shareholder in NUTX with 1.43% of the stake, The Vanguard Group, Inc. holds 9,478,085 shares worth 9,478,085. A second-largest stockholder of NUTX, Truist Bank, holds 3,448,351 shares, controlling over 0.52% of the firm’s shares. Millennium Management LLC is the third largest shareholder in NUTX, holding 2,084,688 shares or 0.32% stake. With a 1.40% stake in NUTX, the Vanguard Total Stock Market ETF is the largest stakeholder. A total of 9,268,251 shares are owned by the mutual fund manager. The Fidelity Nasdaq Composite Index F, which owns about 0.06% of NUTX stock, is the second-largest Mutual Fund holder. It holds 384,948 shares valued at 0.11 million. Vanguard Russell 2000 Growth Inde holds 0.06% of the stake in NUTX, owning 375,760 shares worth 0.1 million.
An Overview of Recent Financials:
Understanding a company as a customer does not mean you will understand it as an investor. The wise investor uses quantitative research to analyze metrics such as revenue, net income, and earnings. In its fiscal quarter reported on Jun 29, 2023, NUTX reported revenue of $58.05M and operating income of $2.51M. The EBITDA in the recently reported quarter was $9.21M and diluted EPS was -$0.03.
Analysts Ratings:
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for NUTX since 0 analysts follow the stock currently. In the same way, a target price assigned to a stock can also reveal much about its potential. With NUTX analysts setting a high price target of $2.50 and a low target of $2.25, the average target price over the next 12 months is $2.38. Based on these targets, NUTX could surge 941.67% to reach the target high and rise by 837.5% to reach the target low. Reaching the average price target will result in a growth of 891.67% from current levels.
EPS: Estimates vs Actual
It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy.
Summary of Insider Activity:
Insiders traded NUTX stock several times over the past three months with 0 Buys and 0 Sells. In these transactions, 0 shares were bought while 0 shares were sold. The number of buy transactions has increased to 13 while that of sell transactions has risen to 2 over the past year. The total number of shares bought during that period was 1,238,007 while 169,378 shares were sold.
